WallStSmart

NCS Multistage Holdings Inc (NCSM)vsNOV Inc. (NOV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

NOV Inc. generates 4662% more annual revenue ($8.74B vs $183.63M). NCSM leads profitability with a 12.9% profit margin vs 1.7%. NCSM trades at a lower P/E of 8.0x. NCSM earns a higher WallStSmart Score of 67/100 (B-).

NCSM

Strong Buy

67

out of 100

Grade: B-

Growth: 5.3Profit: 6.5Value: 8.3Quality: 8.0
Piotroski: 5/9Altman Z: 1.62

NOV

Buy

50

out of 100

Grade: C-

Growth: 3.3Profit: 5.0Value: 4.7Quality: 7.0
Piotroski: 3/9Altman Z: 1.95
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NCSMUndervalued (+90.3%)

Margin of Safety

+90.3%

Fair Value

$404.82

Current Price

$72.69

$332.13 discount

UndervaluedFair: $404.82Overvalued
NOVSignificantly Overvalued (-634.7%)

Margin of Safety

-634.7%

Fair Value

$2.65

Current Price

$19.62

$16.97 premium

UndervaluedFair: $2.65Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NCSM4 strengths · Avg: 9.8/10
P/E RatioValuation
8.0x10/10

Attractively priced relative to earnings

Price/BookValuation
1.5x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0710/10

Conservative balance sheet, low leverage

Return on EquityProfitability
20.1%9/10

Every $100 of equity generates 20 in profit

NOV1 strengths · Avg: 10.0/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

Areas to Watch

NCSM3 concerns · Avg: 3.7/10
EPS GrowthGrowth
3.0%4/10

3.0% earnings growth

Altman Z-ScoreHealth
1.624/10

Distress zone — elevated risk

Market CapQuality
$177.02M3/10

Smaller company, higher risk/reward

NOV4 concerns · Avg: 3.3/10
Altman Z-ScoreHealth
1.954/10

Grey zone — moderate risk

Return on EquityProfitability
2.4%3/10

ROE of 2.4% — below average capital efficiency

Profit MarginProfitability
1.7%3/10

1.7% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : NCSM

The strongest argument for NCSM centers on P/E Ratio, Price/Book, Debt/Equity. Revenue growth of 12.5% demonstrates continued momentum.

Bull Case : NOV

The strongest argument for NOV centers on Price/Book. PEG of 1.19 suggests the stock is reasonably priced for its growth.

Bear Case : NCSM

The primary concerns for NCSM are EPS Growth, Altman Z-Score, Market Cap.

Bear Case : NOV

The primary concerns for NOV are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 50.0x leaves little room for execution misses. Thin 1.7% margins leave little buffer for downturns.

Key Dynamics to Monitor

NOV carries more volatility with a beta of 0.93 — expect wider price swings.

NCSM is growing revenue faster at 12.5% — sustainability is the question.

NOV generates stronger free cash flow (472M), providing more financial flexibility.

Monitor OIL & GAS EQUIPMENT & SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NCSM scores higher overall (67/100 vs 50/100) and 12.5% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

NCS Multistage Holdings Inc

ENERGY · OIL & GAS EQUIPMENT & SERVICES · USA

NCS Multistage Holdings, Inc. provides engineering products and support services for oil and natural gas well completions and field development strategies in the United States, Canada, and internationally. The company is headquartered in Houston, Texas.

NOV Inc.

ENERGY · OIL & GAS EQUIPMENT & SERVICES · USA

NOV Inc. is an American multinational corporation based in Houston, Texas. It is a leading worldwide provider of equipment and components used in oil and gas drilling and production operations, oilfield services, and supply chain integration services to the upstream oil and gas industry.

Visit Website →

Want to dig deeper into these stocks?